Literature DB >> 11815607

Characterization of RhoA-binding kinase ROKalpha implication of the pleckstrin homology domain in ROKalpha function using region-specific antibodies.

Xiang-qun Chen1, Ivan Tan, Chong Han Ng, Christine Hall, Louis Lim, Thomas Leung.   

Abstract

Rho-binding kinase alpha (ROKalpha) is a serine/threonine kinase with multiple functional domains involved in actomyosin assembly. It has previously been documented that the C terminus part of ROKalpha interacts with the N-terminal kinase domain and thereby regulates its catalytic activity. Here we used antibodies against different domains of ROKalpha and were able to reveal some structural aspects that are essential for the specific functions of ROKalpha. Antibodies against the kinase domain revealed that this part of the protein is highly complex and inaccessible. Further experiments confirmed that this domain could undergo inter- and intramolecular interactions in a complex manner, which regulates the kinase catalytic activity. Other antibodies that raised against the coiled-coil domain, Rho binding domain, and the pleckstrin homology (PH) domain were all effective in recognizing the native proteins in an immunoprecipitation assay. Only the anti-Rho binding domain antibodies could activate the kinase independent of RhoA. The PH antibodies had no apparent effects on the catalytic activity but were effective in blocking actomyosin assembly and cell contractility. Likewise, mutations of the PH domains can abrogate its dominant negative effects on actin morphology. The subsequent disruption of endogenous ROK localization to the actomyosin network by overexpressing the PH domain is supportive of a role of the PH domain of ROK in targeting the kinase to these structures.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11815607     DOI: 10.1074/jbc.M109839200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

1.  RhoE binds to ROCK I and inhibits downstream signaling.

Authors:  Kirsi Riento; Rosa M Guasch; Ritu Garg; Boquan Jin; Anne J Ridley
Journal:  Mol Cell Biol       Date:  2003-06       Impact factor: 4.272

2.  New insights into the structure-function relationships of Rho-associated kinase: a thermodynamic and hydrodynamic study of the dimer-to-monomer transition and its kinetic implications.

Authors:  John D Doran; Xun Liu; Paul Taslimi; Ahmad Saadat; Ted Fox
Journal:  Biochem J       Date:  2004-12-01       Impact factor: 3.857

Review 3.  PAK and other Rho-associated kinases--effectors with surprisingly diverse mechanisms of regulation.

Authors:  Zhou-shen Zhao; Ed Manser
Journal:  Biochem J       Date:  2005-03-01       Impact factor: 3.857

Review 4.  Role of rho kinase in the functional and dysfunctional tonic smooth muscles.

Authors:  Márcio A F de Godoy; Satish Rattan
Journal:  Trends Pharmacol Sci       Date:  2011-04-15       Impact factor: 14.819

Review 5.  ROCK and Rho: biochemistry and neuronal functions of Rho-associated protein kinases.

Authors:  André Schmandke; Antonio Schmandke; Stephen M Strittmatter
Journal:  Neuroscientist       Date:  2007-10       Impact factor: 7.519

Review 6.  Rho kinase (ROCK) inhibitors.

Authors:  James K Liao; Minoru Seto; Kensuke Noma
Journal:  J Cardiovasc Pharmacol       Date:  2007-07       Impact factor: 3.105

Review 7.  Rho-kinase: regulation, (dys)function, and inhibition.

Authors:  Ehsan Amin; Badri Nath Dubey; Si-Cai Zhang; Lothar Gremer; Radovan Dvorsky; Jens M Moll; Mohamed S Taha; Luitgard Nagel-Steger; Roland P Piekorz; Avril V Somlyo; Mohammad R Ahmadian
Journal:  Biol Chem       Date:  2013-11       Impact factor: 3.915

8.  A molecular mechanism of P-loop pliability of Rho-kinase investigated by molecular dynamic simulation.

Authors:  Keigo Gohda; Toshio Hakoshima
Journal:  J Comput Aided Mol Des       Date:  2008-04-15       Impact factor: 3.686

9.  Little ROCK is a ROCK1 pseudogene expressed in human smooth muscle cells.

Authors:  Maria Claudia Montefusco; Kristen Merlo; Crystal D Bryan; Howard K Surks; Steven E Reis; Michael E Mendelsohn; Gordon S Huggins
Journal:  BMC Genet       Date:  2010-04-14       Impact factor: 2.797

10.  From autoinhibition to inhibition in trans: the Raf-1 regulatory domain inhibits Rok-alpha kinase activity.

Authors:  Théodora Niault; Izabela Sobczak; Katrin Meissl; Gregory Weitsman; Daniela Piazzolla; Gabriele Maurer; Florian Kern; Karin Ehrenreiter; Matthias Hamerl; Ismail Moarefi; Thomas Leung; Oliviero Carugo; Tony Ng; Manuela Baccarini
Journal:  J Cell Biol       Date:  2009-11-02       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.